Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950103-16-016688
Filing Date
2016-09-29
Accepted
2016-09-29 16:21:18
Documents
6
Effectiveness Date
2016-09-29

Document Format Files

Seq Description Document Type Size
1 FORM S-8 dp68999_s8.htm S-8 63023
2 EXHIBIT 4.1 dp68999_ex0401.htm EX-4.1 415728
3 EXHIBIT 5 dp68999_ex0500.htm EX-5 34158
4 EXHIBIT 23.2 dp68999_ex2302.htm EX-23.2 1920
5 EXHIBIT 99.2 dp68999_ex9902.htm EX-99.2 50588
6 EXHIBIT 99.3 dp68999_ex9903.htm EX-99.3 55620
  Complete submission text file 0000950103-16-016688.txt   622030
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-213865 | Film No.: 161910202
SIC: 2834 Pharmaceutical Preparations